Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effect of APOKYN treatment in rapid and reliable
improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or
unreliable onset of levodopa (L-dopa) action.
Phase:
Phase 4
Details
Lead Sponsor:
US WorldMeds LLC
Collaborators:
Cape Cod Clinical Research Inc. ClinData Services, Inc.
Treatments:
Antiemetics Apomorphine Carbidopa Carbidopa, levodopa drug combination Levodopa Trimethobenzamide